Centene Receives a Downgrade at Morgan Stanley
<p>Morgan Stanley analysts adjusted their rating for <a href='https://financialmodelingprep.com/financial-summary/CNC'>Centene (NYSE:CNC)</a> from Overweight to Equalweight. The new price target stands at $73.00, down from the previous $94.00.</p>
<p>The analysts explained the downgrade by expressing diminished confidence in the predictability and consistency of Centene's long-term earnings growth trajectory. They pointed out uncertainties emerging around the multi-year recovery of Medicare Advantage Star Ratings and the company's potential to secure future Medicaid RFPs. These uncertainties are increasingly raising doubts about Centene's foundational long-term growth narrative.</p>

NYSE:CNC